JSH-009, CAS 2247481-08-7

Product Description: JSH-009 is a novel, highly selective CDK9 inhibitor critical for regulating transcription elongation. JSH-009 demonstrated significant in vitro and in vivo efficacy against acute myeloid leukemia (AML)[1].

Formula: C25H35ClN6O2S

References: [1]Wang L, et al. Discovery of a novel and highly selective CDK9 kinase inhibitor (JSH-009) with potent antitumor efficacy in preclinical acute myeloid leukemia models. Invest New Drugs. 2020 Oct;38(5):1272-1281.

CAS Number: 2247481-08-7

Molecular Weight: 519.10

Compound Purity: 99.21

Research Area: Cancer; Others

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: CDK

• SKU: MEXHY-X0009-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-X0009-10.1
• Package Unit: 10mM/1mL
• Quantity Unit: STK